What is a GLP-1 surgery hold?
A GLP-1 surgery hold is the time before elective surgery when a patient pauses their GLP-1 medication so that the stomach is actually empty when anesthesia starts. The standard rule of "no food after midnight" assumes a stomach that empties at a normal rate. GLP-1 medications change that rate — and they keep changing it for far longer than the medication's own half-life would suggest.
The clinical concern isn't blood sugar or weight loss — it's aspiration. Stomach contents entering the lungs during anesthesia induction is a rare but serious complication. The GLP-1 hold protocol exists to make sure that risk doesn't show up on the day of surgery because of a medication everyone forgot to talk about.
Why GLP-1 medications increase surgical risk
GLP-1 receptor agonists (the class that includes semaglutide, tirzepatide, liraglutide, dulaglutide) work in part by slowing gastric motility. Clinical studies show a 30-50% reduction in gastric emptying on GLP-1 therapy. That effect is part of why the medications work for weight management — patients feel full longer because food sits in the stomach longer.
The same effect creates the anesthesia problem. Standard fasting guidelines — typically 6-8 hours for solids and 2 hours for clear liquids before surgery — assume the stomach will be empty at the start of anesthesia. On GLP-1 medications, that assumption breaks. Patients arrive for surgery having followed NPO instructions exactly and still have food and liquid in the stomach.
The duration of the gastric-emptying effect is the more surprising part. The half-life of semaglutide is about seven days, but GI endoscopy reports from clinical colleagues repeatedly find residual gastric contents in patients who stopped their weekly injection two to four weeks earlier. That observation is what drove many anesthesia providers in private practice to extend the hold window past the original ASA floor.
Which medications need a hold
The full list of GLP-1 receptor agonists and the typical hold recommendation in 2026:
| Brand | Generic | Frequency | Hold window |
|---|---|---|---|
| Ozempic | semaglutide | Weekly injection | ~14 days (ASA floor: 1 week) |
| Wegovy | semaglutide | Weekly injection | ~14 days (ASA floor: 1 week) |
| Mounjaro | tirzepatide | Weekly injection | ~14 days (ASA floor: 1 week) |
| Zepbound | tirzepatide | Weekly injection | ~14 days (ASA floor: 1 week) |
| Rybelsus | semaglutide (oral) | Daily tablet | 24-48 hours |
| Trulicity | dulaglutide | Weekly injection | ~14 days (ASA floor: 1 week) |
| Saxenda | liraglutide | Daily injection | 24-48 hours |
| Victoza | liraglutide | Daily injection | 24-48 hours |
| Compounded GLP-1 | semaglutide / tirzepatide | Weekly (most common) | Match formulation; default to weekly window |
The most-missed category in practice is compounded GLP-1 from weight-loss clinics. Patients often don't classify compounded semaglutide or tirzepatide as "the same as Ozempic" on intake forms — they think of it as a separate weight-loss program. The screening question should ask about brand-name medications and weight-loss clinic prescriptions explicitly.
How long is the hold window
1 week for weekly injections; 24 hours for daily formulations.
The official starting point. Many anesthesia providers consider this the minimum, not the target.
~14 days for weekly injections; 24-48 hours for daily oral.
Aligned with endoscopy findings of delayed emptying past the 1-week ASA floor. Common in private-practice anesthesia.
The final hold window is a clinical judgment call by the anesthesia provider and surgeon based on the patient's dose, comorbidities (especially diabetes or known gastroparesis), and the planned procedure. Higher doses, longer cases, and patients with known GI symptoms (nausea, early satiety, vomiting) often warrant longer holds.
ASA guidance and the real-world gap
The American Society of Anesthesiologists issued formal guidance on GLP-1 medications and elective surgery starting in 2023, with updates as more clinical experience accumulates. The headline recommendation: hold weekly GLP-1 medications for at least one week before elective procedures; hold daily formulations for at least 24 hours.
The real-world gap between guidance and practice is large. The ASA writes guidelines; private-practice ASCs and office-based suites have to implement them. The implementation challenges are predictable:
- •The patient's PCP may not flag the GLP-1 hold on the clearance letter.
- •The surgical coordinator doing the workflow review is not licensed to make anesthesia judgment calls.
- •The patient may not consider compounded weight-loss-clinic GLP-1 to be the same as the brand-name medication.
- •The anesthesia provider often sees the chart for the first time on the day of surgery.
The fix is structural: a pre-op screening workflow that explicitly asks about GLP-1 medications by brand and by clinic source, well before the day of surgery. The detailed clinical breakdown is in the GLP-1 surgery hold Field Note, and where it fits in the larger clearance workflow is covered in the pre-op clearance pillar guide.
For patients: what to do
If you take a GLP-1 medication and you have surgery scheduled, the practical steps:
- 1
Tell your surgeon and your anesthesia provider — by name — about every GLP-1 medication you take. Include compounded prescriptions from weight-loss clinics or telehealth providers.
- 2
Ask specifically: 'How many days before surgery should I stop this medication?' Your anesthesia provider will give you a date.
- 3
Mark the stop date on a calendar. Do not stop earlier than instructed without checking — some patients try to be conservative and create different problems.
- 4
Follow your normal NPO instructions on top of the GLP-1 hold. The hold replaces nothing in the standard fasting protocol; it's an addition.
- 5
If you accidentally take a dose during the hold window, tell your surgical office immediately. Do not wait until the morning of surgery.
You will not be in trouble for asking the question. Anesthesia providers wantto know about GLP-1 medications well before the day of surgery — it's the missed conversations that cause cancellations.
For surgeons and anesthesia: the screening protocol
The structural fix for GLP-1 misses in private practice is a screening workflow that doesn't depend on the patient volunteering the medication on the intake form:
Include Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Trulicity, Saxenda, and Victoza in the screening question, plus a specific question about compounded weight-loss medications.
Patients sometimes don't think to mention compounded GLP-1 from a weight-loss clinic because they don't consider it 'a prescription.' Ask explicitly about weight-loss clinic medications and telehealth-prescribed injectables.
Knowing the last dose date is what lets the anesthesia provider set the appropriate hold window. Without the date, the conservative default is the longest hold for the formulation.
Patients with nausea, vomiting, or early satiety on GLP-1 therapy are at higher risk for delayed gastric emptying. Document and consider extended hold or rapid sequence induction.
A verbal 'stop two weeks before surgery' converts to written instructions with a calendar date. Confirm the patient understands by reading the date back.
AI pre-op screening tools catch the medication review step at scale — see the anesthesia AI pillar guide for how the workflow integrates, and how AI pre-op charting works for the mechanics.
What happens if the hold is missed
If the GLP-1 medication wasn't held appropriately and this is discovered before induction, the anesthesia provider has three options, in increasing order of conservativeness:
For lower-risk cases and shorter holds, proceed with rapid sequence induction (RSI) to minimize aspiration risk during airway management.
Direct visualization of stomach contents to decide whether to proceed. A full stomach on ultrasound shifts the decision toward postponement.
For elective cases with significant aspiration risk, the safest call is to reschedule until the hold window has been met. The patient comes back. The case proceeds safely. The economics are real but recoverable.
The economics of a same-day cancellation in private practice are covered in detail in the hidden cost of same-day surgical cancellations. A single GLP-1 miss can cost a high-volume practice the margin on half a day of OR time.
When to restart after surgery
Restart timing depends on three factors: the type of procedure, the post-operative recovery, and whether the patient is tolerating solid food. For most uncomplicated outpatient procedures, patients can resume their GLP-1 within a few days of surgery once normal eating has resumed and post-op nausea has settled.
For inpatient surgeries, procedures involving the GI tract, or cases with significant post-op nausea or restricted diet, restart is delayed accordingly. The prescribing physician for the GLP-1 medication and the surgical team should coordinate the restart date as part of the post-operative plan.
Frequently asked questions
What is a GLP-1 surgery hold?
A GLP-1 surgery hold is the period before elective surgery when patients are instructed to pause their GLP-1 medication — Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus — to reduce the risk of aspiration during anesthesia. The hold is required because GLP-1 medications slow gastric emptying, leaving food and liquid in the stomach long after standard NPO windows would normally clear it.
How long should I stop Ozempic, Wegovy, or Mounjaro before surgery?
For weekly injectables — Ozempic, Wegovy, Mounjaro, Zepbound — current practice ranges from the ASA's 1-week floor to a 14-day hold, with the more conservative 14-day window favored by anesthesia providers who have seen endoscopy findings of full stomachs weeks after the last injection. For daily oral semaglutide (Rybelsus), 24-48 hours is typically sufficient. The final hold window is set by your anesthesia provider and surgeon based on your specific case, dose, and risk factors.
Why do GLP-1 medications increase surgical risk?
GLP-1 medications slow gastric motility — clinical studies show a 30-50% reduction in gastric emptying. The standard fasting window before surgery (typically 6-8 hours for solids, 2 hours for clear liquids) assumes normal stomach emptying. With GLP-1 medications, that assumption breaks down. Patients can present for surgery with food and liquid still in the stomach despite following NPO instructions, which significantly raises the risk of aspiration — stomach contents entering the lungs — during anesthesia induction.
Which medications are GLP-1 receptor agonists?
The most common GLP-1 receptor agonists in 2026 are semaglutide (brand names Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound). Liraglutide (Victoza, Saxenda) and dulaglutide (Trulicity) are also in the GLP-1 class. Compounded semaglutide and tirzepatide from weight-loss clinics also count — patients sometimes don't think to mention these because they weren't dispensed at a pharmacy. The screening question should name medications by brand and ask specifically about weight-loss compounded options.
What does the ASA say about GLP-1 medications before surgery?
The American Society of Anesthesiologists (ASA) issued formal guidance starting in 2023, recommending the hold of GLP-1 medications before elective procedures — one week for weekly formulations and 24 hours or longer for daily formulations as a starting floor. The guidance has been updated as more clinical experience accumulates. Many anesthesia providers favor a more conservative 14-day hold for weekly injectables based on endoscopy findings showing delayed gastric emptying well beyond the ASA floor.
What happens if I forget to stop Ozempic before surgery?
If the medication wasn't held appropriately, the case will likely be delayed or rescheduled. Anesthesia providers may proceed with a modified plan — rapid sequence induction, point-of-care gastric ultrasound to check stomach contents, or delaying the case until the hold window has been met. The exact path is a clinical judgment call by the anesthesia provider based on the case urgency, patient risk factors, and what's seen in pre-op holding. The safest path is always to confirm the hold ahead of time and not be in this position on the day of surgery.
When can I restart my GLP-1 medication after surgery?
Restart timing depends on the procedure, the recovery, and whether you can tolerate solid food. Most patients can resume their GLP-1 within a few days of an uncomplicated outpatient procedure once normal eating has resumed. For inpatient surgeries or procedures with restricted post-op diet, restart is delayed accordingly. Your anesthesia provider or prescribing physician should confirm the restart date as part of post-operative instructions.
Do GLP-1 medications affect blood sugar during surgery?
Yes, GLP-1 medications affect glucose regulation, but the more pressing operative concern in 2026 is the gastric-emptying delay rather than glycemic effects. For diabetic patients on GLP-1 medications, the anesthesia and surgical team will manage glucose intraoperatively. The hold protocol is driven by the aspiration-risk concern, not the glucose concern.
Should patients on weight-loss clinic GLP-1 still stop before surgery?
Yes. Compounded semaglutide or tirzepatide prescribed by weight-loss clinics or telehealth providers behaves clinically the same as pharmacy-dispensed Ozempic or Mounjaro. Patients sometimes don't think of compounded medications as 'GLP-1' or don't mention them on intake forms. The screening should ask specifically about weight-loss clinic and compounded medications, not just brand-name prescriptions.
How is GLP-1 screening different in private-practice vs hospital settings?
Private-practice ASCs and office-based surgical suites carry more risk of missed GLP-1 holds because the medication review often happens through a coordinator-driven workflow rather than a hospital pre-admission clinic. The coordinator screens, the PCP letter may or may not mention the medication, and the anesthesia provider sees the chart for the first time on the day of surgery. This is why a structured pre-op screening tool that explicitly asks about GLP-1 medications by brand and by clinic source materially reduces same-day cancellations in private practice.
MyPreOp.ai catches the GLP-1 miss in 30 seconds.
Built by a practicing CRNA. Reads the chart and the medication list, flags every GLP-1 by brand name (including compounded prescriptions), calculates the hold window, and surfaces the date for the coordinator and the patient. HIPAA-compliant. Validated on 475+ real clearances.
No contracts. Cancel anytime. AANA-aligned, ASA-aligned, HIPAA-compliant.